Correlation analysis of serum HMGB1 with clinical indicators in children with sepsis

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Sepsis is a dysregulated bodily response, and high mobility group box 1 (HMGB1) acts as a pro-inflammatory mediator of its pathogenesis. However, the association between HMGB1 and complications or clinical indicators in pediatric sepsis patients remain incompletely understood. Methods Children aged 1 month − 18 years admitted to our hospital (March 2022 - December 2023) with a discharge diagnosis of sepsis were enrolled. Correlation analysis was performed to explore the relationship between HMGB1 levels and general information, clinical characteristics, and laboratory results. Additionally, HMGB1-related immune infiltration was analyzed via the CIBERSORT algorithm using peripheral blood transcriptome data of pediatric sepsis from the GEO database. Results A total of 90 sepsis patients and 21 healthy controls were included. Compared with the control group, the sepsis group presented greater body temperature and serum HMGB1 levels (P < 0.05). HMGB1 was positively correlated with PCT, IL-6, the organ involvement count, D-dimer, the neutrophil percentage, lactate, and blood ammonia (P < 0.05) and negatively correlated with the CD3 + CD4 + T-cell percentage (P < 0.05). Moreover, HMGB1 expression was inversely correlated with regulatory T cells (Tregs) and naïve CD4 + T cells but positively correlated with resting and activated CD4 memory T cells. Conclusion Serum HMGB1 is significantly elevated in pediatric sepsis patients and closely associated with organ dysfunction, coagulation disorders, increased inflammatory markers, and immune dysfunction. The underlying mechanisms warrant further investigation.

Article activity feed